Stocks to Watch: Ventyx Biosciences, Lexicon Pharmaceuticals, Immunic
By Ben Glickman Ventyx released results from its trial of VTX002 in the treatment of ulcerative colitis. The company found that its treatment had a...
Source: marketwatch.com
Page 12 - Lxrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lxrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lxrx Today - Breaking & Trending Today
Xerox (NYSE:XRX) Earns Buy Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Xerox (NYSE:XRX – Free Report) in a report released on Thursday morning. The firm issued a buy rating on the information technology services provider’s stock. Xerox Trading Down 1.6 % Shares of XRX opened at $15.08 on Thursday. The stock has a fifty day moving average price of $15.81 […]
Source: tickerreport.com
Lexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart Drug
By Josh Beckerman Lexicon Pharmaceuticals shares rose 20% to $1.20 after-hours as its Inpefa heart failure drug received preferred formulary status with...
Source: marketwatch.com
Xerox, Mastercraft Boat, and More Stocks See Action From Activist Investors
Perceptive Advisors lifted its stake in pharmaceutical firm Soleno Therapeutics. Coliseum Capital bought more shares of powerboat maker Mastercraft.
Source: marketwatch.com
Insider Selling: Xerox Holdings Co. (NYSE:XRX) Major Shareholder Sells $542,445,773.76 in Stock
Xerox Holdings Co. (NYSE:XRX – Get Free Report) major shareholder Carl C. Icahn sold 34,245,314 shares of the firm’s stock in a transaction that occurred on Thursday, September 28th. The shares were sold at an average price of $15.84, for a total value of $542,445,773.76. The transaction was disclosed in a filing with the Securities […]
Source: dailypolitical.com